Non-small-cell lung cancer
Conditions
Interventions
During thoracoscopic lobectomy or segmentectomy, once the chest cavity is open, indocyanine green (ICG) and autologousblood are injected around the tumor, and the optimal dose of ICG is determined so
Sponsors
Tane Shinya
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Primary lung cancer patients who will receive thoracoscopic lobectomy or segmentectomy. 2. The tumor located in the outer one-third of lung field. 3. The patints with 18 years old or more, and 79 years old or less 4. The patients having provided signed informed consent.
Exclusion criteria
Exclusion criteria: 1. The patients who are allergic to iodine. 2. The patients who will receive middle lobe lobectomy 3. The pregnant patients. 4. The patients who are judged to be eligible by investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The evaluation of visualization and identification of subpleural lymphatic pathway using NIR imaging system. The examination for the direction of lymphatic spread according to each tumor-located lobe. | — |
Secondary
| Measure | Time frame |
|---|---|
| The evaluation of identification of fluoreseced lobe-specific mediastinal lymph node on NIR imaging system. The rate of adverse event during follow-up period | — |
Contacts
Public ContactShinya Tane
Kobe University Hospital
Outcome results
None listed